Esophageal atresia and co-occurring major anomalies in Denmark 1994-2021: A nationwide register-based study
In brief
Nearly half of nonsyndromic esophageal atresia cases had another major anomaly
In Denmark's nationwide cohort, 47.6% of infants with nonsyndromic esophageal atresia had at least one additional major anomaly, most often cardiovascular; overall prevalence was 2.61 per 10,000 screened live births and rose modestly over time. The findings support systematic assessment beyond the esophagus, but cardiac estimates varied sharply depending on whether septal defects were counted.
- Journal
- European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie (Q2)
- Published
- 16 November 2026
- Study design
- Cohort / observational study
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Ulrik Lausten-Thomsen, Paula Louise Hedley, Kristin M Conway, Katrine Margrethe Løfberg, Lars Søndergaard Johansen, Paul Romitti, et al.
- PMID
- 43039353
- DOI
- 10.1055/a-3003-6057
Why clinicians should know about it
- Picked for Pediatric Surgery (top studies of the week, 22 November 2026): Nationwide cohort informs associated anomalies and assessment in oesophageal atresia
Abstract
BACKGROUND: Esophageal atresia (EA) frequently co-occurs with additional major congenital anomalies. Long-term national trends and the influence of anomaly definitions on registry estimates remain incompletely characterized. METHODS: We conducted a nationwide, register-based cohort study of infants born in Den-mark during 1994-2021, who participated in the neonatal screening program, which has near-complete coverage. Infants were identified using ICD-10-DK codes in linked national registries. Associated major congenital anomalies were classified with reference to EURO-CAT guidance. Temporal trends were assessed using Poisson regression models. Pheno-types were classified as syndromic or non-syndromic; non-syndromic cases were further classified as isolated or with co-occurring major anomalies. RESULTS: Among 1,696,357 screened infants, 442 were diagnosed with EA, corresponding to a birth prevalence of 2.61 per 10,000 screened live births (95% CI 2.37 - 2.86). EA preva-lence increased by an estimated 1.6% annually (95% CI 0.4-2.9%; p=0.0073). Syndromic EA accounted for 18.3% of cases, with relatively stable proportions over time. Among non-syndromic cases, 47.6% had at least one co-occurring major anomaly, most commonly car-diovascular anomalies. After excluding atrial and ventricular septal defects, cardiac anoma-lies were recorded in 8.8% overall (28.4% of syndromic and 4.4% of non-syndromic cases). CONCLUSIONS: EA prevalence among screened live-born infants was consistent with international estimates and showed a modest model-based increase over time. Nearly half of non-syndromic infants had an additional major anomaly, supporting systematic multisystem assessment. Cardiac-anomaly estimates were strongly influenced by inclusion of atrial and ventricular septal de-fects, which should be considered when comparing registry studies.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.